Management of children with severe asthma exacerbation in the emergency department

Pediatric Drugs

Volumn 4, Issue 3, 2002, Pages 141-148

  Volovitz, Benjamin ^a   Nussinovitch, Moshe ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; IPRATROPIUM BROMIDE; MAGNESIUM SULFATE; METHYLPREDNISOLONE; PREDNISOLONE; SALBUTAMOL; TERBUTALINE; THEOPHYLLINE;

ASTHMA; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; EMERGENCY WARD; HUMAN; HYPOXEMIA; METERED DOSE INHALER; OXYGEN THERAPY; PATIENT EDUCATION; PRIORITY JOURNAL; RELIABILITY; REVIEW;

EID: 0036217528     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128072-200204030-00001     Document Type: Review

References (75)

1. Increase in hospital admission for childhood asthma, trends in referral, severity, and re-admission from 1970 to 1985 in a health region of the United Kingdom
2. Ambulatory care visits for asthma: United States, 1993-94
3. Prospective multicenter study of relapse after treatment for acute asthma among children presenting to the emergency department
4. Relapse following treatment of acute asthma in the emergency department
5. The use of peak expiratory flow rate measurements in respiratory disease
6. Guidelines for diagnosis and management of asthma
7. The treatment of critical status asthmaticus in children
8. The relationship between oxygen saturation and the clinical assessment of acutely wheezing infants and children
9. Air or oxygen as driving gas for nebulised salbutamol
10. Evaluation of SaO2 as predictor of outcome in 280 children presenting with acute asthma
11. Bias and precision of pulse oximeter and arterial oximeters
12. Prolonged hypoxaemia after nebulised salbutamol
13. Predictive value of oxygen saturation in emergency evaluation of asthmatic children
14. Clinical application of beta-agonists
15. A beta2-adrenergic agonist for use in asthma: Pharmacology; pharmacokinetics, clinical efficacy and adverse effects
16. Guidelines on the management of asthma
17. Are nebulizers obsolete for administering asthma medications to infants and children?
18. Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma
19. Holding chambers versus nebulisers for beta-agonist treatment of acute asthma: A systematic review of randomised controlled trials (Cochrane Review)
20. Randomised trial of spacer v nebulizer for acute asthma
21. Metered-dose inhalers with spacers vs. nebulizers for pediatric asthma
22. Substitution of metered-dose inhalers for hand-held nebulizers: Success and cost saving in a large acute-care hospital
23. Poor inhalation technique, even after inhalation instruction, in children with asthma
24. Beta adrenergic receptors and their regulation
25. Prospective randomized trial of epinephrine. Metaproterenol and both in the prehospital treatment of the adult patient
26. Randomised trial of intravenous salbutamol in early management of acute severe asthma in children
27. Continuous nebulization for status asthmaticus
28. Early emergency department treatment of acute asthma with systemic corticosteroids (Cochrane Review)
29. Controlled trial of oral prednisolone in the emergency department treatment of children with acute asthma
30. Effect of a single oral dose of prednisolone in acute childhood asthma
31. Outpatient management of acute exacerbations of asthma in children
32. Methylprednisolone therapy for acute asthma in infants and toddlers: A controlled clinical trial
33. Corticosteroids for preventing relapse following acute exacerbations of asthma (Cochrane Review)
34. Intravenous methylprednisolone efficacy in status asthmaticus of children
35. Early administration of hydrocortisone in the emergency room treatment of acute asthma: A controlled clinical trial
36. Inhaled glucocorticoids for asthma
37. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma (Cochrane Review)
38. Nebulized budesonide versus oral steroid in severe exacerbations of childhood asthma
39. Nebulized dexamethasone versus oral prednisone in the emergency treatment of asthmatic children
40. Efficacy of nebulized budesonide compared to oral prednisolone in acute bronchial asthma
41. Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children in the emergency department A controlled comparative study with oral prednisolone
42. Inhaled budesonide in acute asthma
43. Efficacy of nebulized fluticasone propionate compared with oral prednisolone in children with an acute exacerbation of asthma
44. A comparison of inhaled fluticasone and oral prednisolone for children with severe acute asthma
45. Application of asthma action plan to childhood asthma: A national survey
46. Treatment of acute asthmatic exacerbations with an increased dose of inhaled steroid
47. High-dose budesonide is helpful in acute asthma
48. Use of inhaled corticosteroids in controlling acute asthma exacerbation in children at home
49. Treatment of acute, episodic asthma in preschool children using intermittent high dose inhaled steroids at home
50. Drug therapy: Ipratropium bromide
51. An international perspective on anticholinergic therapy
52. The role of anticholinergic bronchodilator therapy in children
53. Combined inhaled anticholinergics and beta2-agonists for initial treatment of acute asthma in children (Cochrane Review)
54. Anti-cholinergic drugs for wheeze in children under the age of two years (Cochrane Review)
55. Treatment of acute wheezing and dyspnea attacks in children under 2 years old: Inhalation of fenoterol plus ipratropium bromide versus fenoterol
56. Update on the management of status asthmaticus
57. Is it useful to add an anticholinergic treatment to beta-2 adrenergic medication in acute asthma attack?
58. Efficacy of ipratropium bromide in acute childhood asthma a meta-analysis
59. Randomized controlled trial of ipratropium bromide and frequent low doses of salbutamol in the management of mild and moderate acute pediatric asthma
60. Aminophylline treatment in severe acute asthma: A meta-analysis
61. Safety and efficacy of theophylline in children with asthma
62. Bronchodilating effect of intravenous magnesium sulfate in bronchial asthma
63. Acute effect of intravenous magnesium sulfate on airway obstruction of asthmatic patients
64. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department (Cochrane Review)
65. Can hospital use be a measure of need for health care?
66. Audit strategies to reduce hospital admission for acute asthma
67. Effect of readmission on increasing hospital admission for asthma in children
68. Impact of a nurse-led home management training programme in children admitted to hospital with acute asthma: A randomized controlled study
69. Reduction in resource utilization by an asthma outreach program
70. Successful implementation of spacer treatment guideline for acute asthma
71. The impact of health education on frequency and cost of health care use by low income children with asthma
72. Bioequivalent dose of budesonide and prednisolone in moderate and severe asthma
73. Nebulized budesonide for the treatment of moderate to severe asthma in infants and toddlers
74. Structured discharge procedure for children admitted to hospital with acute asthma: A randomized controlled trial of nursing practice